BioCeramic Therapeutics Ltd, a spin-out company from Imperial College co-founded by Dr Molly Stevens and Professor Robert Hill, receives its first financing round.

This funding will enable the company to press forward with its plans to develop a range of bioceramic and nanostructured scaffold products, designed to help patients suffering from musculoskeletal conditions.